GGrantIndex
Sort

326,823 grants matching clinical trial

COMPREHENSIVE CANCER CENTER

$2,669,072
Ohio State University · P30 · FY2004 · CA

Pelvic floor Disorders Network-Data Coordinating Center

$2,668,707
Catherine A Spino · University Of Michigan At Ann Arbor · U01 · FY2008 · HD

Implantable, Degradable Drug Delivery Devices for Non-Opioid Post-Surgical Pain Management

$2,668,301
Kelly Anne Burke · University Of Connecticut Storrs · R18 · FY2025 · EB

Center for Cancer Research Clinical Trials Data Management Service

$2,668,203
Caryn Steakley · Division Of Basic Sciences - Nci · ZID · FY2011 · CA

UofL RBL Operations, Workforce Development and Pandemic Preparedness Research

$2,667,645
Kenneth E Palmer · University Of Louisville · UC7 · FY2024 · AI

Hormonal, Metabolic and Signaling Interactions in PAH

$2,667,336
James E Loyd · Vanderbilt University · P01 · FY2012 · HL

Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations

$2,667,277
Sandra Ann Springer · Yale University · U01 · FY2023 · DA

Cancer Immunotherapy Trials Network Central Operations and Statistical Center

$2,667,211
Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2014 · CA

Network Chair for the Pacific Northwest DPBRN

$2,667,122
Timothy A Derouen · University Of Washington · U01 · FY2008 · DE

Precision Delivery and Imaging to Enhance Solid Tumor Therapy

$2,667,097
Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · P01 · FY2020 · CA

Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes

$2,666,884
Andrew Scott Weyrich · University Of Utah · U54 · FY2012 · HL

PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM

$2,666,802
Fred Hutchinson Cancer Research Center · P50 · FY2002 · CA

Barrier Damage and The Immune CascadeNorthwestern University CounterACT Center of Excellence (NUCCX)

$2,666,779
Kurt Lu · Northwestern University At Chicago · U54 · FY2024 · AR

Shared Pharmacotherapeutic Strategies for Cannabinoid & Opioid Use Disorders

$2,666,246
Frances Rudnick Levin · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · U54 · FY2014 · DA

Multilevel Interventions for Maternal Health and Disparities (MIRACLE) Center

$2,666,072
Cristian Ioan Meghea · Henry Ford Health + Michigan State University Health Sciences · U54 · FY2025 · HD

Northwestern University Clinical Trial Unit

$2,665,678
Robert L. Murphy · Northwestern University At Chicago · UM1 · FY2013 · AI

Carbon Monoxide: Novel Opportunities for Therapy

$2,665,482
Mark A Perrella · Brigham And Women'S Hospital · P01 · FY2014 · HL

Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations

$2,665,428
Sandra Ann Springer · Yale University · U01 · FY2021 · DA

A Safety and Efficacy Study of AAV2-hAADC for AADC Deficiency

$2,665,330
Krystof S Bankiewicz · Ohio State University · R01 · FY2024 · NS

DAIT CLINICAL SITE MONITORING CENTER

$2,665,320
Mary Glessner · Ppd Development Lp · N01 · FY2019 · AI

University of North Carolina Global HIV Prevention and Treatment Clinical Trials

$2,665,274
Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2015 · AI

DISCOVERY - Repository Core

$2,665,146
Karl Gerard Helmer · Massachusetts General Hospital · U19 · FY2024 · NS

Mechanisms and Therapy of Chronic Graft-vs.-Host Disease

$2,665,095
Corey S Cutler · Dana-Farber Cancer Inst · P01 · FY2022 · HL

Telomere Diseases

$2,664,647
Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL

Development of negative allosteric modulators at the mu opioid receptor

$2,664,000
Susruta Majumdar · Washington University · UG3 · FY2025 · DA